Integrated Diagnostics, a molecular diagnostics company, has announced its launch of a new operating division, InDi Imaging. The division is creating a new generation of PET imaging probes using the company's innovative protein catalyzed capture (PCC) agent technology. PCCs, initially developed for molecular IVDs, will be employed as rationally designed, in vivo diagnostic imaging probes that mimic the properties of antibodies and biologics in PET molecular imaging, with the benefit of being chemically stable, synthetic small molecules.